Alternative options for DNA-based experimental therapy of β-thalassemia.
about
An international effort to cure a global health problem: A report on the 19th Hemoglobin Switching Conference.α-Globin as a molecular target in the treatment of β-thalassemiaPeptide nucleic acids: a review on recent patents and technology transfer.Recent trends for novel options in experimental biological therapy of β-thalassemia.Recent trends in the gene therapy of β-thalassemia.Hemin induces mitophagy in a leukemic erythroblast cell line.Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cellsInduction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproductsGeneration and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.An Aγ-globin G->A gene polymorphism associated with β039 thalassemia globin gene and high fetal hemoglobin production.The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders.Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin.Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels.Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations
P2860
Q33850615-79CB46EC-1AA8-41A5-B316-7143FA561FC5Q35836891-122EFB37-77A0-4906-B79C-93EFFB20D3D8Q38176989-E8BA3CC1-E75C-4D5C-AFC1-9BBF16164619Q38220695-64119A5A-5F21-4C4A-8493-B795276E40E8Q38367473-58EFBB40-7100-4B9D-A5D7-392E55AADAE3Q38803104-1DFCBB9B-8DD8-49A3-B280-569B5FEDD7B2Q38939602-194F991F-4096-4DD5-9630-89EBF2A74FB0Q39814424-1C0AEF80-584E-4D10-B0AF-DDAD09241E85Q40746113-5E58186C-7945-4DBB-BA8C-36612D0B7893Q41554655-249CD315-78C7-4EDF-8683-B19B94ACDA90Q42253045-5F9B9B35-7009-47A3-AD66-D305DBA40B35Q43142280-796B6166-621B-4EDA-9948-FEDD1ADFA8BBQ53771829-D9CA359D-B2DB-4F52-BC07-468BD68440BFQ54585888-1B6D1CB4-6E0D-4F55-8391-C20B4AC826E0
P2860
Alternative options for DNA-based experimental therapy of β-thalassemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Alternative options for DNA-based experimental therapy of β-thalassemia.
@en
Alternative options for DNA-based experimental therapy of β-thalassemia.
@nl
type
label
Alternative options for DNA-based experimental therapy of β-thalassemia.
@en
Alternative options for DNA-based experimental therapy of β-thalassemia.
@nl
prefLabel
Alternative options for DNA-based experimental therapy of β-thalassemia.
@en
Alternative options for DNA-based experimental therapy of β-thalassemia.
@nl
P2860
P1476
Alternative options for DNA-based experimental therapy of β-thalassemia
@en
P2093
Roberto Gambari
P2860
P304
P356
10.1517/14712598.2012.665047
P407
P577
2012-04-01T00:00:00Z